Skip to main navigation
Skip to search
Skip to main content
Vrije Universiteit Brussel Home
Help & FAQ
Link opens in a new tab
English
Nederlands
Search content at Vrije Universiteit Brussel
Home
Research units
Profiles
Projects
Research output
Activities
Equipment
Prizes
Press/Media
Student theses
Datasets
Impacts
Therapeutic TriMix-dendritic cell vaccination in melanoma patients with and without evaluable disease.
Thielemans, Kris
(Administrative Promotor)
Neyns, Bart
(Co-Promotor)
Physiology
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Vaccination
100%
Diseases
100%
Immunogenicity
33%
Neoplasm
33%
Melanoma Antigen
33%
Melanoma Vaccine
16%
Messenger RNA
16%
Cohort Study
16%
Malignant Neoplasm
16%
Chimeric Protein
16%
Efficacy Study
16%
Nursing and Health Professions
Diseases
50%
Melanoma
50%